Logo image of CCAP

CRESCENT CAPITAL BDC INC (CCAP) Stock Fundamental Analysis

NASDAQ:CCAP - Nasdaq - US2256551092 - Common Stock - Currency: USD

15.08  -0.44 (-2.84%)

After market: 15.08 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CCAP. CCAP was compared to 232 industry peers in the Capital Markets industry. There are concerns on the financial health of CCAP while its profitability can be described as average. CCAP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CCAP had positive earnings in the past year.
CCAP had a positive operating cash flow in the past year.
Each year in the past 5 years CCAP has been profitable.
In multiple years CCAP reported negative operating cash flow during the last 5 years.
CCAP Yearly Net Income VS EBIT VS OCF VS FCFCCAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

1.2 Ratios

CCAP has a Return On Assets (2.97%) which is in line with its industry peers.
CCAP has a Return On Equity (6.81%) which is in line with its industry peers.
CCAP's Return On Invested Capital of 4.07% is in line compared to the rest of the industry. CCAP outperforms 51.29% of its industry peers.
Industry RankSector Rank
ROA 2.97%
ROE 6.81%
ROIC 4.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCAP Yearly ROA, ROE, ROICCCAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

CCAP has a better Profit Margin (26.20%) than 66.81% of its industry peers.
CCAP's Profit Margin has declined in the last couple of years.
The Operating Margin of CCAP (44.43%) is better than 77.59% of its industry peers.
CCAP's Operating Margin has declined in the last couple of years.
CCAP has a Gross Margin (46.29%) which is in line with its industry peers.
CCAP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 44.43%
PM (TTM) 26.2%
GM 46.29%
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
CCAP Yearly Profit, Operating, Gross MarginsCCAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

0

2. Health

2.1 Basic Checks

CCAP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCAP Yearly Shares OutstandingCCAP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CCAP Yearly Total Debt VS Total AssetsCCAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

CCAP has an Altman-Z score of 0.44. This is a bad value and indicates that CCAP is not financially healthy and even has some risk of bankruptcy.
CCAP has a Altman-Z score of 0.44. This is in the lower half of the industry: CCAP underperforms 67.24% of its industry peers.
CCAP has a debt to FCF ratio of 210.82. This is a negative value and a sign of low solvency as CCAP would need 210.82 years to pay back of all of its debts.
CCAP has a Debt to FCF ratio of 210.82. This is in the lower half of the industry: CCAP underperforms 60.34% of its industry peers.
A Debt/Equity ratio of 1.24 is on the high side and indicates that CCAP has dependencies on debt financing.
CCAP's Debt to Equity ratio of 1.24 is on the low side compared to the rest of the industry. CCAP is outperformed by 61.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 210.82
Altman-Z 0.44
ROIC/WACCN/A
WACCN/A
CCAP Yearly LT Debt VS Equity VS FCFCCAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

CCAP has a Current Ratio of 0.34. This is a bad value and indicates that CCAP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CCAP (0.34) is worse than 82.33% of its industry peers.
A Quick Ratio of 0.34 indicates that CCAP may have some problems paying its short term obligations.
CCAP has a Quick ratio of 0.34. This is amonst the worse of the industry: CCAP underperforms 82.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
CCAP Yearly Current Assets VS Current LiabilitesCCAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

3

3. Growth

3.1 Past

CCAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.51%.
Measured over the past 5 years, CCAP shows a small growth in Earnings Per Share. The EPS has been growing by 7.26% on average per year.
CCAP shows a decrease in Revenue. In the last year, the revenue decreased by -3.11%.
Measured over the past years, CCAP shows a very strong growth in Revenue. The Revenue has been growing by 29.83% on average per year.
EPS 1Y (TTM)-11.51%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-40.79%
Revenue 1Y (TTM)-3.11%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-16.35%

3.2 Future

Based on estimates for the next years, CCAP will show a very negative growth in Earnings Per Share. The EPS will decrease by -13.17% on average per year.
Based on estimates for the next years, CCAP will show a decrease in Revenue. The Revenue will decrease by -6.78% on average per year.
EPS Next Y-18.48%
EPS Next 2Y-12.85%
EPS Next 3Y-13.17%
EPS Next 5YN/A
Revenue Next Year-10.51%
Revenue Next 2Y-6.61%
Revenue Next 3Y-6.78%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCAP Yearly Revenue VS EstimatesCCAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
CCAP Yearly EPS VS EstimatesCCAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.76 indicates a rather cheap valuation of CCAP.
Based on the Price/Earnings ratio, CCAP is valued cheaply inside the industry as 88.79% of the companies are valued more expensively.
CCAP is valuated cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.82, the valuation of CCAP can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCAP indicates a rather cheap valuation: CCAP is cheaper than 84.48% of the companies listed in the same industry.
CCAP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.17.
Industry RankSector Rank
PE 6.76
Fwd PE 7.82
CCAP Price Earnings VS Forward Price EarningsCCAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CCAP.
Industry RankSector Rank
P/FCF 130.48
EV/EBITDA N/A
CCAP Per share dataCCAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CCAP's earnings are expected to decrease with -13.17% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.93
EPS Next 2Y-12.85%
EPS Next 3Y-13.17%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.94%, CCAP is a good candidate for dividend investing.
CCAP's Dividend Yield is a higher than the industry average which is at 8.15.
CCAP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 10.94%

5.2 History

CCAP has been paying a dividend for over 5 years, so it has already some track record.
CCAP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years4
Div Non Decr Years4
CCAP Yearly Dividends per shareCCAP Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

148.85% of the earnings are spent on dividend by CCAP. This is not a sustainable payout ratio.
DP148.85%
EPS Next 2Y-12.85%
EPS Next 3Y-13.17%
CCAP Yearly Income VS Free CF VS DividendCCAP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M
CCAP Dividend Payout.CCAP Dividend Payout, showing the Payout Ratio.CCAP Dividend Payout.PayoutRetained Earnings

CRESCENT CAPITAL BDC INC

NASDAQ:CCAP (6/2/2025, 8:00:02 PM)

After market: 15.08 0 (0%)

15.08

-0.44 (-2.84%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-11 2025-08-11
Inst Owners47.93%
Inst Owner Change23.4%
Ins Owners1.09%
Ins Owner Change0%
Market Cap558.86M
Analysts85
Price Target19.47 (29.11%)
Short Float %0.73%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield 10.94%
Yearly Dividend1.9
Dividend Growth(5Y)N/A
DP148.85%
Div Incr Years4
Div Non Decr Years4
Ex-Date08-29 2025-08-29 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.1%
Min EPS beat(2)-15.91%
Max EPS beat(2)-4.28%
EPS beat(4)1
Avg EPS beat(4)-2.74%
Min EPS beat(4)-15.91%
Max EPS beat(4)9.46%
EPS beat(8)5
Avg EPS beat(8)2.86%
EPS beat(12)7
Avg EPS beat(12)2.91%
EPS beat(16)11
Avg EPS beat(16)3.99%
Revenue beat(2)0
Avg Revenue beat(2)-6.07%
Min Revenue beat(2)-8.38%
Max Revenue beat(2)-3.76%
Revenue beat(4)2
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-8.38%
Max Revenue beat(4)3.96%
Revenue beat(8)5
Avg Revenue beat(8)-0.45%
Revenue beat(12)7
Avg Revenue beat(12)0.44%
Revenue beat(16)9
Avg Revenue beat(16)1.13%
PT rev (1m)-1.72%
PT rev (3m)-3.78%
EPS NQ rev (1m)-6.24%
EPS NQ rev (3m)-6.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.15%
Revenue NQ rev (1m)-2.69%
Revenue NQ rev (3m)-2.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 6.76
Fwd PE 7.82
P/S 2.95
P/FCF 130.48
P/OCF 130.48
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)2.23
EY14.79%
EPS(NY)1.93
Fwd EY12.79%
FCF(TTM)0.12
FCFY0.77%
OCF(TTM)0.12
OCFY0.77%
SpS5.1
BVpS19.62
TBVpS19.62
PEG (NY)N/A
PEG (5Y)0.93
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 6.81%
ROCE 5.15%
ROIC 4.07%
ROICexc 4.1%
ROICexgc 4.12%
OM 44.43%
PM (TTM) 26.2%
GM 46.29%
FCFM 2.26%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 210.82
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.47
Cash Conversion N/A
Profit Quality 8.64%
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z 0.44
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)123.47%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.51%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-40.79%
EPS Next Y-18.48%
EPS Next 2Y-12.85%
EPS Next 3Y-13.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.11%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-16.35%
Revenue Next Year-10.51%
Revenue Next 2Y-6.61%
Revenue Next 3Y-6.78%
Revenue Next 5YN/A
EBIT growth 1Y-6.46%
EBIT growth 3Y21.99%
EBIT growth 5Y23.29%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.94%
OCF growth 3YN/A
OCF growth 5YN/A